Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hee Dong Han

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Neoplasia (New York, N.Y.)|May 2, 2013
Biologic effects of dopamine on tumor vasculature in ovarian carcinomaMyrthala Moreno-Smith, Sun Joo Lee, Chunhua Lu, et al.
Cancer Discovery|September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatmentMasato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticlesMian M K Shahzad, Lingegowda S Mangala, Hee Dong Han, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
The Journal of Clinical Investigation|April 12, 2016
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawalMonika Haemmerle, Justin Bottsford-Miller, Sunila Pradeep, et al.
Nature Communications|June 18, 2015
The ZNF304-integrin axis protects against anoikis in cancerBurcu Aslan, Paloma Monroig, Ming-Chuan Hsu, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.
The New England Journal of Medicine|February 17, 2012
Paraneoplastic thrombocytosis in ovarian cancerRebecca L Stone, Alpa M Nick, Iain A McNeish, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Neoplasia (New York, N.Y.)|May 2, 2013
Biologic effects of dopamine on tumor vasculature in ovarian carcinomaMyrthala Moreno-Smith, Sun Joo Lee, Chunhua Lu, et al.
Cancer Discovery|September 5, 2013
Therapeutic synergy between microRNA and siRNA in ovarian cancer treatmentMasato Nishimura, Eun-Jung Jung, Maitri Y Shah, et al.
Neoplasia (New York, N.Y.)|April 8, 2011
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticlesMian M K Shahzad, Lingegowda S Mangala, Hee Dong Han, et al.
Cancer Research|April 19, 2014
Notch3 pathway alterations in ovarian cancerWei Hu, Tao Liu, Cristina Ivan, et al.
The Journal of Clinical Investigation|April 12, 2016
FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawalMonika Haemmerle, Justin Bottsford-Miller, Sunila Pradeep, et al.
Nature Communications|June 18, 2015
The ZNF304-integrin axis protects against anoikis in cancerBurcu Aslan, Paloma Monroig, Ming-Chuan Hsu, et al.
Cancer Cell|December 10, 2014
Copy number gain of hsa-miR-569 at 3q26.2 leads to loss of TP53INP1 and aggressiveness of epithelial cancersPradeep Chaluvally-Raghavan, Fan Zhang, Sunila Pradeep, et al.
Cell Reports|December 7, 2017
Differential Effects of EGFL6 on Tumor versus Wound AngiogenesisKyunghee Noh, Lingegowda S Mangala, Hee-Dong Han, et al.
Cancer Cell|July 16, 2014
Hematogenous metastasis of ovarian cancer: rethinking mode of spreadSunila Pradeep, Seung W Kim, Sherry Y Wu, et al.
The New England Journal of Medicine|February 17, 2012
Paraneoplastic thrombocytosis in ovarian cancerRebecca L Stone, Alpa M Nick, Iain A McNeish, et al.
Pageof 12